Ann MacDougall

Ann MacDougall

Director/Board Member at ALOPEXX, INC.
72 year
Health Technology
Consumer Services
Commercial Services

Profile

Ann MacDougall is currently an Independent Director at Alopexx, Inc., a Director at Atmos Xr since 2017, and a Director at Strongminds Zambia.
Former roles include Chairman at Progenics Pharmaceuticals, Inc. from 2019 to 2020, Independent Director at Opiant Pharmaceuticals, Inc. from 2016 to 2023, General Counsel at PricewaterhouseCoopers LLP from 1994 to 2007, Principal at US West, Inc., Chief Administrative Officer at Acumen Fund, Inc., President at Encore.
Org from 2014 to 2017, and a position at Coopers & Lybrand LLP in 2004.
Education includes undergraduate studies at Tufts University and graduate studies at Brooklyn Law School.

Ann MacDougall active positions

CompaniesPositionStart
ALOPEXX, INC. Director/Board Member -
Atmos Xr
Director/Board Member 01/10/2017
Strongminds Zambia
Director/Board Member -

Former positions of Ann MacDougall

CompaniesPositionEnd
OPIANT PHARMACEUTICALS, INC. Director/Board Member 02/03/2023
PROGENICS PHARMACEUTICALS, INC. Chairman 19/06/2020
Encore.Org
President 01/10/2017
Comptroller/Controller/Auditor 01/01/2007
Corporate Officer/Principal -
See the detail of Ann MacDougall's experience

Training of Ann MacDougall

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

90

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Commercial Services

Health Technology

Communications

Consumer Services

Consumer Services

Finance

Encore.Org

Health Technology

Atmos Xr

Strongminds Zambia

  1. Stock Market
  2. Insiders
  3. Ann MacDougall